AGIOS PHARMACEUTICALS INC

Profile

Company Names

AGIOS PHARMACEUTICALS INC

Addresses

38 SIDNEY STREET, 2ND FLOOR, CAMBRIDGE, MA 02139

Phone Numbers

617-649-8600

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$86,823,938.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-11-16 
$78,000,001.00 
$78,000,001.00 
$0.00 
Equity 
1
2010-04-14 
$8,823,937.00 
$8,823,937.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LEWIS 
C. 
CANTLEY 
DIRECTOR
AGIOS PHARMACEUTICALS INC
DOUG 
 
COLE 
DIRECTOR
AVEDRO INC   |  RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  AGIOS PHARMACEUTICALS INC   |  SEVENTH SENSE BIOSYSTEMS, INC.   |  RECEPTOS, INC.   |  BLACK HILLS FIBERGLASS, LLC   |  AV THERAPEUTICS, INC.   |  EWELLNESS HEALTHCARE CORP   |  TORQUE THERAPEUTICS, INC.
DUNCAN 
 
HIGGONS 
EXECUTIVE OFFICER
AGIOS PHARMACEUTICALS INC   |  JOUNCE THERAPEUTICS, INC.
PERRY 
 
KARSEN 
DIRECTOR
AGIOS PHARMACEUTICALS INC   |  ALLIQUA, INC.   |  E-SCAPE BIO, INC.   |  ESCAPE BIO, INC.   |  JOUNCE THERAPEUTICS, INC.   |  GRAPHITE BIO, INC.
JOHN 
 
MARAGANORE 
DIRECTOR
TALIGEN THERAPEUTICS INC   |  REGULUS THERAPEUTICS INC.   |  AGIOS PHARMACEUTICALS INC   |  ANDROS MEDICINES INC.
ROBERT 
 
NELSEN 
DIRECTOR
FORGE INC   |  RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  AGIOS PHARMACEUTICALS INC   |  KILIMANJARO ENERGY, INC.   |  NEUROGESX INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SYROS PHARMACEUTICALS, INC.   |  FATE THERAPEUTICS INC   |  CENEXYS, INC.   |  JUNO THERAPEUTICS, INC.   |  BELLEROPHON THERAPEUTICS LLC   |  FARADAY PHARMACEUTICALS, INC.   |  SAPPHIRE ENERGY, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARIVALE INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  GOSSAMER BIO, INC.   |  VIR BIOTECHNOLOGY, INC.   |  BEAM THERAPEUTICS INC.   |  GRAIL, INC.   |  APEX NEURO HOLDINGS, INC.   |  NUTCRACKER THERAPEUTICS, INC.   |  SANA BIOTECHNOLOGY, INC.   |  INSITRO, INC.   |  NATIONAL RESILIENCE, INC.   |  MEDICAL CREATIONS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  RIPPL CARE, INC.   |  SEAPORT THERAPEUTICS, INC.
DAVID 
 
SCHENKEIN 
EXECUTIVE OFFICER, DIRECTOR
AGIOS PHARMACEUTICALS INC   |  FOUNDATION MEDICINE, INC.   |  BLUEPRINT MEDICINES CORP   |  TREELINE BIOSCIENCES, INC.
KEVIN 
 
STARR 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  ZAFGEN, INC.   |  AGIOS PHARMACEUTICALS INC   |  PANOPTICA, INC.   |  MYOKARDIA INC   |  THIRD ROCK VENTURES III, L.P.   |  SAGE THERAPEUTICS, INC.   |  GLOBAL BLOOD THERAPEUTICS, INC.   |  DECIBEL THERAPEUTICS, INC.
MARC 
 
TESSIER-LAVIGNE 
DIRECTOR
AGIOS PHARMACEUTICALS INC   |  JUNO THERAPEUTICS, INC.   |  DENALI THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-11-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-11-16 
2010-04-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-04-14 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#